NCT06687876: Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy
- State
- Under way
- Phase
- Phase 2
- People
- 14 planned
- Started
- 9 Mar 2025
- Primary completion
- Dec 2026
- Arms
- Metformin
- Results
- None posted
- 14 Nov 2024: Trial registered
- 9 Mar 2025: Trial started